Slingshot members are tracking this event:
Merck (MRK) and Pfizer (PFE) Plan to Submit NDA By End of 2016 for Ertugliflozin in Combination with Januvia (sitagliptin) and Metformin in Treatment of Type 2 Diabetes
Slingshot Insights Explained
Mar 06, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords New Drug Applciation, Ertugliflozin, Januvia, Sitagliptin, Metformin, Type 2 Diabetes, Fda